icpeptide@gmail.comThis website has been online since June 2016.

AF12198 – Immunology – Antigens/Epitotes/Pools/Librairies

AF12198 is a selective receptor antagonist to the human cytokine, type 1 interleukin-1 (IL-1) and thus blocks IL-1β signalling. AF12198 can inhibit IL-1-induced IL-8 production by human dermal fibroblasts and IL-1-induced intercellular adhesion molecule-1 (ICAM-1) expression by endothelial cells. AF12198 also blocks IL-1 induction of IL-6 and down regulates IL-6 induction in monkeys. AF12198 does not bind the human type II IL-1 receptor, or the murine type I IL-1 receptor. IL-1 influences a wide range of immune and inflammatory responses. Sustained expression of even low levels of IL-1 can be harmful in chronic inflammatory diseases such as rheumatoid arthritis and inflammatory bowel disease.

Technical specification

SequenceAc-FEWTPGWYQJYALPL-NH2, J is L-azetidine-2-carboxylic acid
MW1.895.9 g/mol
Purity> 95%
Counter-ionTFA Salts
Delivery formatLyophilized

Price

ProductSizePrice €Price $
CRB1001289-0.5 mg0.5 mg282 €339 $
CRB1001289-1 mg1 mg385 €462 $
CRB1001289-5 mg5 mg815 €978 $
CRB1001289-10 mg10 mg1111 €1334 $